| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.63e-09 | 14 | 27 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.84e-07 | 9 | 27 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.84e-07 | 9 | 27 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.16e-07 | 46 | 27 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 5.28e-06 | 3 | 27 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 5.28e-06 | 3 | 27 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.60e-05 | 129 | 27 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.82e-05 | 151 | 27 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.94e-05 | 152 | 27 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 9.95e-05 | 182 | 27 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.04e-04 | 184 | 27 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.17e-04 | 1180 | 27 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.57e-04 | 78 | 27 | 3 | GO:0003725 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 1.59e-04 | 14 | 27 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.83e-04 | 15 | 27 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 2.09e-04 | 16 | 27 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | transporter activity | 2.17e-04 | 1289 | 27 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.97e-04 | 19 | 27 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.46e-04 | 102 | 27 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | RNA cap binding | 3.64e-04 | 21 | 27 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 9.62e-04 | 34 | 27 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.95e-04 | 334 | 27 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.10e-03 | 343 | 27 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.87e-03 | 59 | 27 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.13e-03 | 758 | 27 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.17e-03 | 62 | 27 | 2 | GO:0003678 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.18e-03 | 459 | 27 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.33e-03 | 465 | 27 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.47e-03 | 65 | 27 | 2 | GO:0004714 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.60e-03 | 230 | 27 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.80e-03 | 793 | 27 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.96e-03 | 78 | 27 | 2 | GO:0003724 | |
| GeneOntologyMolecularFunction | channel activity | 5.13e-03 | 525 | 27 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.16e-03 | 526 | 27 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 5.21e-03 | 80 | 27 | 2 | GO:0008186 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.87e-03 | 85 | 27 | 2 | GO:0019199 | |
| GeneOntologyMolecularFunction | amide binding | 7.45e-03 | 299 | 27 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 8.82e-03 | 318 | 27 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 9.52e-03 | 627 | 27 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.16e-02 | 664 | 27 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.27e-02 | 127 | 27 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.44e-02 | 709 | 27 | 4 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.63e-02 | 145 | 27 | 2 | GO:0004713 | |
| GeneOntologyMolecularFunction | kinase activity | 1.85e-02 | 764 | 27 | 4 | GO:0016301 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.87e-02 | 156 | 27 | 2 | GO:0019838 | |
| GeneOntologyMolecularFunction | helicase activity | 1.92e-02 | 158 | 27 | 2 | GO:0004386 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.36e-07 | 48 | 27 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.36e-07 | 48 | 27 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 5.69e-07 | 126 | 27 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.80e-06 | 685 | 27 | 8 | GO:0050808 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.73e-06 | 98 | 27 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.74e-05 | 663 | 27 | 7 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.76e-05 | 664 | 27 | 7 | GO:0099177 | |
| GeneOntologyBiologicalProcess | cell junction organization | 2.39e-05 | 974 | 27 | 8 | GO:0034330 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.34e-05 | 142 | 27 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.34e-05 | 142 | 27 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 3.90e-05 | 752 | 27 | 7 | GO:1901699 | |
| GeneOntologyBiologicalProcess | response to pain | 3.99e-05 | 51 | 27 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | regulation of translation at postsynapse | 4.60e-05 | 8 | 27 | 2 | GO:0140245 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 4.60e-05 | 8 | 27 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | behavioral fear response | 5.88e-05 | 58 | 27 | 3 | GO:0001662 | |
| GeneOntologyBiologicalProcess | behavioral defense response | 6.19e-05 | 59 | 27 | 3 | GO:0002209 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 6.84e-05 | 61 | 27 | 3 | GO:1904645 | |
| GeneOntologyBiologicalProcess | fear response | 8.66e-05 | 66 | 27 | 3 | GO:0042596 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse | 1.28e-04 | 13 | 27 | 2 | GO:0140243 | |
| GeneOntologyBiologicalProcess | membrane organization | 1.34e-04 | 914 | 27 | 7 | GO:0061024 | |
| GeneOntologyBiologicalProcess | regulation of behavioral fear response | 1.49e-04 | 14 | 27 | 2 | GO:2000822 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.50e-04 | 931 | 27 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.50e-04 | 931 | 27 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.58e-04 | 939 | 27 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.58e-04 | 1272 | 27 | 8 | GO:1901698 | |
| GeneOntologyBiologicalProcess | regulation of fear response | 1.71e-04 | 15 | 27 | 2 | GO:1903365 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.73e-04 | 217 | 27 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 2.01e-04 | 976 | 27 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.16e-04 | 230 | 27 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | regulation of neurotrophin TRK receptor signaling pathway | 2.22e-04 | 17 | 27 | 2 | GO:0051386 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 2.50e-04 | 705 | 27 | 6 | GO:0072657 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 2.92e-04 | 249 | 27 | 4 | GO:0010976 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.44e-04 | 748 | 27 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 3.63e-04 | 107 | 27 | 3 | GO:0007029 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 3.65e-04 | 264 | 27 | 4 | GO:0099504 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 3.88e-04 | 1450 | 27 | 8 | GO:1901701 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.15e-04 | 112 | 27 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 4.81e-04 | 284 | 27 | 4 | GO:0007626 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 4.83e-04 | 118 | 27 | 3 | GO:0046928 | |
| GeneOntologyBiologicalProcess | localization within membrane | 4.85e-04 | 798 | 27 | 6 | GO:0051668 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.87e-04 | 285 | 27 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.94e-04 | 286 | 27 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 4.98e-04 | 802 | 27 | 6 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 5.57e-04 | 819 | 27 | 6 | GO:0120039 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 5.71e-04 | 125 | 27 | 3 | GO:0016079 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 5.82e-04 | 826 | 27 | 6 | GO:0048858 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 6.11e-04 | 28 | 27 | 2 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 6.11e-04 | 28 | 27 | 2 | GO:0007413 | |
| GeneOntologyBiologicalProcess | synapse assembly | 6.52e-04 | 308 | 27 | 4 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 6.60e-04 | 309 | 27 | 4 | GO:1901888 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 6.83e-04 | 1194 | 27 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 6.93e-04 | 313 | 27 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 7.47e-04 | 866 | 27 | 6 | GO:0055082 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.48e-04 | 566 | 27 | 5 | GO:0007409 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 7.50e-04 | 31 | 27 | 2 | GO:0061615 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 7.62e-04 | 321 | 27 | 4 | GO:0099003 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 7.66e-04 | 569 | 27 | 5 | GO:0034329 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.99e-04 | 32 | 27 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 8.11e-04 | 141 | 27 | 3 | GO:0051588 | |
| GeneOntologyBiologicalProcess | dendrite development | 8.93e-04 | 335 | 27 | 4 | GO:0016358 | |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 9.02e-04 | 34 | 27 | 2 | GO:0048011 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine morphogenesis | 9.02e-04 | 34 | 27 | 2 | GO:0061003 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 9.23e-04 | 338 | 27 | 4 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 9.33e-04 | 339 | 27 | 4 | GO:0033500 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 9.70e-04 | 150 | 27 | 3 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.06e-03 | 612 | 27 | 5 | GO:0010975 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.30e-03 | 166 | 27 | 3 | GO:0014074 | |
| GeneOntologyBiologicalProcess | axon development | 1.31e-03 | 642 | 27 | 5 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 1.43e-03 | 981 | 27 | 6 | GO:0019725 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.51e-03 | 175 | 27 | 3 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.51e-03 | 175 | 27 | 3 | GO:0050657 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.52e-03 | 387 | 27 | 4 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 1.56e-03 | 667 | 27 | 5 | GO:0060627 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.59e-03 | 178 | 27 | 3 | GO:0051236 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.59e-03 | 392 | 27 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | 1.61e-03 | 672 | 27 | 5 | GO:0010256 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 1.64e-03 | 395 | 27 | 4 | GO:0050803 | |
| GeneOntologyBiologicalProcess | dendrite extension | 1.65e-03 | 46 | 27 | 2 | GO:0097484 | |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 1.72e-03 | 47 | 27 | 2 | GO:0038179 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.77e-03 | 185 | 27 | 3 | GO:0099175 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 1.87e-03 | 49 | 27 | 2 | GO:1904646 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.97e-03 | 192 | 27 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 2.06e-03 | 195 | 27 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 2.06e-03 | 195 | 27 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.15e-03 | 198 | 27 | 3 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 2.18e-03 | 53 | 27 | 2 | GO:0071320 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.26e-03 | 54 | 27 | 2 | GO:0048013 | |
| GeneOntologyBiologicalProcess | import into cell | 2.27e-03 | 1074 | 27 | 6 | GO:0098657 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 2.28e-03 | 202 | 27 | 3 | GO:0051963 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 2.43e-03 | 56 | 27 | 2 | GO:0001941 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 2.47e-03 | 442 | 27 | 4 | GO:0050878 | |
| GeneOntologyBiologicalProcess | neuron recognition | 2.70e-03 | 59 | 27 | 2 | GO:0008038 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.04e-07 | 46 | 28 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.63e-06 | 73 | 28 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | dendrite | 1.17e-05 | 858 | 28 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.19e-05 | 860 | 28 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 CACNA1A CACNA1B CACNA1E CACNA1S EEF2K CYFIP1 EPHA3 PENK | 2.02e-05 | 1228 | 28 | 9 | GO:0036477 |
| GeneOntologyCellularComponent | SCAR complex | 1.13e-04 | 12 | 28 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | presynapse | 1.30e-04 | 886 | 28 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | cation channel complex | 2.58e-04 | 235 | 28 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | dendritic spine | 2.88e-04 | 242 | 28 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 3.12e-04 | 247 | 28 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | neuronal cell body | 7.07e-04 | 835 | 28 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | cell body | 1.23e-03 | 929 | 28 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.53e-03 | 378 | 28 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynapse | 1.97e-03 | 1018 | 28 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | axon terminus | 2.72e-03 | 210 | 28 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | perikaryon | 3.22e-03 | 223 | 28 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.65e-03 | 233 | 28 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.92e-03 | 523 | 28 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 5.88e-03 | 550 | 28 | 4 | GO:1990351 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.90e-03 | 277 | 28 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 6.17e-03 | 88 | 28 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.69e-03 | 332 | 28 | 3 | GO:0005788 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.02e-02 | 114 | 28 | 2 | GO:0016528 | |
| MousePheno | abnormal fear/anxiety-related behavior | 5.03e-06 | 919 | 22 | 9 | MP:0002065 | |
| MousePheno | abnormal anxiety-related response | 9.78e-06 | 740 | 22 | 8 | MP:0001362 | |
| MousePheno | abnormal channel response | 1.79e-05 | 33 | 22 | 3 | MP:0003484 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 2.93e-05 | 116 | 22 | 4 | MP:0004753 | |
| MousePheno | enhanced behavioral response to xenobiotic | 1.66e-04 | 69 | 22 | 3 | MP:0009746 | |
| Domain | Ca_chan_IQ | 1.41e-10 | 7 | 28 | 4 | PF08763 | |
| Domain | GPHH | 1.41e-10 | 7 | 28 | 4 | PF16905 | |
| Domain | GPHH_dom | 1.41e-10 | 7 | 28 | 4 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 1.41e-10 | 7 | 28 | 4 | IPR014873 | |
| Domain | Ca_chan_IQ | 1.41e-10 | 7 | 28 | 4 | SM01062 | |
| Domain | VDCCAlpha1 | 8.43e-10 | 10 | 28 | 4 | IPR002077 | |
| Domain | Channel_four-helix_dom | 1.51e-06 | 57 | 28 | 4 | IPR027359 | |
| Domain | - | 1.51e-06 | 57 | 28 | 4 | 1.20.120.350 | |
| Domain | Cytoplasmic_FMR1-int | 2.17e-06 | 2 | 28 | 2 | IPR008081 | |
| Domain | FragX_IP | 2.17e-06 | 2 | 28 | 2 | PF05994 | |
| Domain | SID-1_RNA_chan | 2.17e-06 | 2 | 28 | 2 | PF13965 | |
| Domain | SID1_TM_fam | 2.17e-06 | 2 | 28 | 2 | IPR025958 | |
| Domain | DUF1394 | 1.30e-05 | 4 | 28 | 2 | PF07159 | |
| Domain | DUF1394 | 1.30e-05 | 4 | 28 | 2 | IPR009828 | |
| Domain | Ion_trans_dom | 2.41e-05 | 114 | 28 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.41e-05 | 114 | 28 | 4 | PF00520 | |
| Domain | Ephrin_rec_like | 1.18e-04 | 11 | 28 | 2 | PF07699 | |
| Domain | EPH_lbd | 1.95e-04 | 14 | 28 | 2 | SM00615 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.95e-04 | 14 | 28 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.95e-04 | 14 | 28 | 2 | PS00790 | |
| Domain | EphA2_TM | 1.95e-04 | 14 | 28 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.95e-04 | 14 | 28 | 2 | IPR016257 | |
| Domain | Eph_TM | 1.95e-04 | 14 | 28 | 2 | IPR027936 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.95e-04 | 14 | 28 | 2 | IPR001090 | |
| Domain | Ephrin_lbd | 1.95e-04 | 14 | 28 | 2 | PF01404 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.95e-04 | 14 | 28 | 2 | IPR001426 | |
| Domain | EPH_LBD | 1.95e-04 | 14 | 28 | 2 | PS51550 | |
| Domain | Ephrin_rec_like | 6.36e-04 | 25 | 28 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 6.36e-04 | 25 | 28 | 2 | IPR011641 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.25e-03 | 35 | 28 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.47e-03 | 38 | 28 | 2 | PS00690 | |
| Domain | - | 5.33e-03 | 73 | 28 | 2 | 2.60.120.260 | |
| Domain | DEAD/DEAH_box_helicase_dom | 5.33e-03 | 73 | 28 | 2 | IPR011545 | |
| Domain | DEAD | 5.33e-03 | 73 | 28 | 2 | PF00270 | |
| Domain | TyrKc | 7.66e-03 | 88 | 28 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.66e-03 | 88 | 28 | 2 | IPR020635 | |
| Domain | SAM | 7.66e-03 | 88 | 28 | 2 | SM00454 | |
| Domain | Galactose-bd-like | 8.70e-03 | 94 | 28 | 2 | IPR008979 | |
| Domain | SAM_DOMAIN | 8.88e-03 | 95 | 28 | 2 | PS50105 | |
| Domain | PROTEIN_KINASE_TYR | 9.24e-03 | 97 | 28 | 2 | PS00109 | |
| Domain | SAM | 9.24e-03 | 97 | 28 | 2 | IPR001660 | |
| Domain | Tyr_kinase_AS | 9.24e-03 | 97 | 28 | 2 | IPR008266 | |
| Domain | - | 1.10e-02 | 106 | 28 | 2 | 1.10.150.50 | |
| Domain | Helicase_C | 1.12e-02 | 107 | 28 | 2 | PF00271 | |
| Domain | HELICc | 1.12e-02 | 107 | 28 | 2 | SM00490 | |
| Domain | Helicase_C | 1.14e-02 | 108 | 28 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 1.16e-02 | 109 | 28 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.16e-02 | 109 | 28 | 2 | PS51192 | |
| Domain | DEXDc | 1.16e-02 | 109 | 28 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.18e-02 | 110 | 28 | 2 | IPR014001 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.46e-09 | 11 | 22 | 4 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.86e-08 | 23 | 22 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.51e-08 | 25 | 22 | 4 | M47948 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.40e-07 | 11 | 22 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.40e-07 | 11 | 22 | 3 | M26913 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 7.59e-07 | 47 | 22 | 4 | M19708 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.47e-05 | 6 | 22 | 2 | M47762 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 7.17e-05 | 147 | 22 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 7.96e-05 | 151 | 22 | 4 | M39329 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.50e-04 | 178 | 22 | 4 | M2890 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 4.34e-04 | 20 | 22 | 2 | M47737 | |
| Pathway | WP_MAPK_SIGNALING | 5.17e-04 | 246 | 22 | 4 | M39597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 6.82e-04 | 25 | 22 | 2 | M47716 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 7.03e-04 | 267 | 22 | 4 | M10792 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 9.20e-04 | 29 | 22 | 2 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M47738 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.27e-03 | 34 | 22 | 2 | MM15265 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.42e-03 | 36 | 22 | 2 | M27549 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 2.83e-03 | 51 | 22 | 2 | M39457 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.83e-03 | 51 | 22 | 2 | M27311 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 2.94e-03 | 52 | 22 | 2 | M5785 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.02e-03 | 61 | 22 | 2 | MM15071 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.13e-03 | 211 | 22 | 3 | MM14502 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.69e-03 | 66 | 22 | 2 | MM17074 | |
| Pubmed | 4.22e-11 | 9 | 28 | 4 | 16382099 | ||
| Pubmed | 4.56e-10 | 15 | 28 | 4 | 20188150 | ||
| Pubmed | 4.56e-10 | 15 | 28 | 4 | 24453333 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.67e-10 | 3 | 28 | 3 | 24523520 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.87e-09 | 4 | 28 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.87e-09 | 4 | 28 | 3 | 37141091 | |
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 8825650 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 11296258 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 15451373 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 9.33e-09 | 6 | 28 | 3 | 35324301 | |
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 9238069 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 9.33e-09 | 6 | 28 | 3 | 12827191 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.63e-08 | 7 | 28 | 3 | 35176221 | |
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 28330839 | ||
| Pubmed | Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family. | 6.25e-07 | 2 | 28 | 2 | 17418573 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 6.25e-07 | 2 | 28 | 2 | 23426690 | |
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 6.25e-07 | 2 | 28 | 2 | 28785058 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16381801 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 6.25e-07 | 2 | 28 | 2 | 38128786 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 38155373 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 6.25e-07 | 2 | 28 | 2 | 12074836 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 34327661 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26067272 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 6.25e-07 | 2 | 28 | 2 | 24357318 | |
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 6.25e-07 | 2 | 28 | 2 | 29752658 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 35567753 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15050706 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31324746 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23376566 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 29466725 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.87e-06 | 3 | 28 | 2 | 24394417 | |
| Pubmed | Identification of ocular regulatory functions of core histone variant H3.2. | 1.87e-06 | 3 | 28 | 2 | 36529279 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.87e-06 | 3 | 28 | 2 | 29208674 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 9191109 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.87e-06 | 3 | 28 | 2 | 26507659 | |
| Pubmed | Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. | 1.87e-06 | 3 | 28 | 2 | 22144690 | |
| Pubmed | Increased preproenkephalin mRNA and preprotachykinin mRNA in the striatum of Rolling mouse Nagoya. | 1.87e-06 | 3 | 28 | 2 | 8861630 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 26283199 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 15294869 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 31253182 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 27605705 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20228810 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 15728831 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.75e-06 | 4 | 28 | 2 | 15953418 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 3.75e-06 | 4 | 28 | 2 | 25483588 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.87e-06 | 38 | 28 | 3 | 30786075 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 4.64e-06 | 139 | 28 | 4 | 16985003 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 16787652 | ||
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 6.24e-06 | 5 | 28 | 2 | 8552593 | |
| Pubmed | Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. | 6.24e-06 | 5 | 28 | 2 | 11494128 | |
| Pubmed | Quantitative genetic analysis of brain copper and zinc in BXD recombinant inbred mice. | 9.36e-06 | 6 | 28 | 2 | 16910173 | |
| Pubmed | Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. | 9.36e-06 | 6 | 28 | 2 | 31853374 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 11438699 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 10328888 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 9632142 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 30687000 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 12900400 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 9651528 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 2.16e-05 | 67 | 28 | 3 | 16987237 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 11403717 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 20838624 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 38981622 | ||
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 2.80e-05 | 10 | 28 | 2 | 15048123 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 22171039 | ||
| Pubmed | Action potential-coupled Rho GTPase signaling drives presynaptic plasticity. | 3.42e-05 | 11 | 28 | 2 | 34269176 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 3.53e-05 | 475 | 28 | 5 | 31040226 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 4.10e-05 | 12 | 28 | 2 | 21465626 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 34508581 | ||
| Pubmed | 5.65e-05 | 14 | 28 | 2 | 21228161 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 8.44e-05 | 17 | 28 | 2 | 12971893 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 8.44e-05 | 17 | 28 | 2 | 12217323 | |
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 9463375 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.06e-04 | 19 | 28 | 2 | 12684176 | |
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 10207129 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 1.18e-04 | 20 | 28 | 2 | 11256076 | |
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 9576626 | ||
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 9530499 | ||
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 9267020 | ||
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.30e-04 | 21 | 28 | 2 | 20112066 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.30e-04 | 21 | 28 | 2 | 10495276 | |
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.30e-04 | 21 | 28 | 2 | 10730216 | |
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 1.43e-04 | 22 | 28 | 2 | 21946561 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 1.56e-04 | 23 | 28 | 2 | 25480914 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 1.56e-04 | 23 | 28 | 2 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 1.71e-04 | 24 | 28 | 2 | 16446123 | |
| Pubmed | 1.71e-04 | 24 | 28 | 2 | 22534482 | ||
| Pubmed | HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3. | 1.85e-04 | 25 | 28 | 2 | 27518902 | |
| Pubmed | 2.07e-04 | 143 | 28 | 3 | 20424473 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.57e-04 | 154 | 28 | 3 | 16055720 | |
| Pubmed | 2.97e-04 | 405 | 28 | 4 | 38187761 | ||
| Pubmed | 3.05e-04 | 32 | 28 | 2 | 19320717 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 3.25e-04 | 33 | 28 | 2 | 26830346 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 3.25e-04 | 33 | 28 | 2 | 22357600 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 4.09e-04 | 37 | 28 | 2 | 25798587 | |
| Pubmed | 4.78e-04 | 40 | 28 | 2 | 30898150 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 5.28e-04 | 42 | 28 | 2 | 11439183 | |
| Pubmed | 6.99e-04 | 217 | 28 | 3 | 30619736 | ||
| Interaction | UBXN11 interactions | 3.81e-05 | 51 | 26 | 3 | int:UBXN11 | |
| Interaction | TNIK interactions | 1.12e-04 | 381 | 26 | 5 | int:TNIK | |
| Interaction | NYAP1 interactions | 1.24e-04 | 13 | 26 | 2 | int:NYAP1 | |
| Interaction | NALCN interactions | 1.44e-04 | 14 | 26 | 2 | int:NALCN | |
| Interaction | EPHB2 interactions | 1.59e-04 | 216 | 26 | 4 | int:EPHB2 | |
| Interaction | SCN11A interactions | 1.66e-04 | 15 | 26 | 2 | int:SCN11A | |
| Interaction | ABI1 interactions | 1.80e-04 | 223 | 26 | 4 | int:ABI1 | |
| Interaction | MYO16 interactions | 1.90e-04 | 16 | 26 | 2 | int:MYO16 | |
| Interaction | CGB2 interactions | 2.42e-04 | 18 | 26 | 2 | int:CGB2 | |
| Interaction | NCKAP1L interactions | 3.00e-04 | 20 | 26 | 2 | int:NCKAP1L | |
| Interaction | SCN9A interactions | 3.31e-04 | 21 | 26 | 2 | int:SCN9A | |
| Interaction | PMM1 interactions | 3.31e-04 | 21 | 26 | 2 | int:PMM1 | |
| Interaction | NYAP2 interactions | 3.98e-04 | 23 | 26 | 2 | int:NYAP2 | |
| Interaction | CACNB2 interactions | 3.98e-04 | 23 | 26 | 2 | int:CACNB2 | |
| Interaction | SPIDR interactions | 4.34e-04 | 24 | 26 | 2 | int:SPIDR | |
| Interaction | CACNA1D interactions | 4.34e-04 | 24 | 26 | 2 | int:CACNA1D | |
| Interaction | WASF1 interactions | 4.39e-04 | 116 | 26 | 3 | int:WASF1 | |
| Interaction | EPHA7 interactions | 4.40e-04 | 282 | 26 | 4 | int:EPHA7 | |
| Interaction | CACNB1 interactions | 4.71e-04 | 25 | 26 | 2 | int:CACNB1 | |
| Interaction | CACNB4 interactions | 4.71e-04 | 25 | 26 | 2 | int:CACNB4 | |
| Cytoband | 11p15.4 | 2.46e-04 | 200 | 28 | 3 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 4.67e-03 | 167 | 28 | 2 | chr1q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 4.81e-03 | 564 | 28 | 3 | chr11p15 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.04e-09 | 26 | 16 | 4 | 253 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 6.64e-05 | 14 | 16 | 2 | 1095 | |
| GeneFamily | Olfactory receptors, family 51 | 6.80e-04 | 44 | 16 | 2 | 164 | |
| GeneFamily | Sterile alpha motif domain containing | 2.69e-03 | 88 | 16 | 2 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 8.61e-03 | 160 | 16 | 2 | 555 | |
| GeneFamily | EF-hand domain containing | 1.57e-02 | 219 | 16 | 2 | 863 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 1.13e-05 | 1115 | 27 | 8 | M10371 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.43e-05 | 166 | 27 | 4 | M39026 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP | 4.84e-05 | 198 | 27 | 4 | M5544 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 6.51e-05 | 1035 | 27 | 7 | M9898 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.62e-06 | 20 | 25 | 3 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 4.82e-05 | 174 | 25 | 4 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | Myeloid Cells, MF.Microglia.CNS, CD45low CD11b+ F4/80+, Brain, avg-3 | 9.66e-05 | 406 | 25 | 5 | GSM854326_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_100 | 1.48e-04 | 88 | 25 | 3 | gudmap_kidney_adult_RenalCapsule_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.52e-04 | 234 | 25 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | kidney_e15.5_SmlBldVes_Tie2_k-means-cluster#3_top-relative-expression-ranked_200 | 2.50e-04 | 20 | 25 | 2 | gudmap_kidney_e15.5_SmlBldVes_Tie2_k3_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200 | 2.86e-04 | 110 | 25 | 3 | gudmap_kidney_adult_RenalCapsule_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | 2.93e-04 | 813 | 25 | 6 | gudmap_developingKidney_e11.5_ureteric bud_1000 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 157 | 27 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-06 | 188 | 27 | 4 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-06 | 191 | 27 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.22e-06 | 192 | 27 | 4 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 193 | 27 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 193 | 27 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 193 | 27 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-06 | 196 | 27 | 4 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-06 | 196 | 27 | 4 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-06 | 196 | 27 | 4 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.02e-06 | 199 | 27 | 4 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-06 | 200 | 27 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-06 | 200 | 27 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-06 | 200 | 27 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.17e-05 | 140 | 27 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.08e-04 | 154 | 27 | 3 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.17e-04 | 158 | 27 | 3 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.17e-04 | 158 | 27 | 3 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.17e-04 | 158 | 27 | 3 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 159 | 27 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 161 | 27 | 3 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 161 | 27 | 3 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 163 | 27 | 3 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 163 | 27 | 3 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 1.35e-04 | 166 | 27 | 3 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-04 | 167 | 27 | 3 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 167 | 27 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 168 | 27 | 3 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 168 | 27 | 3 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 169 | 27 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 169 | 27 | 3 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 27 | 3 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 27 | 3 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 173 | 27 | 3 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 1.53e-04 | 173 | 27 | 3 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-04 | 174 | 27 | 3 | 8a8e98e62c2859c004b44dbce6974c9639ebeac6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-04 | 174 | 27 | 3 | 31f7127faabcb1092bb9827db625f57cf7d8240e | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.58e-04 | 175 | 27 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 175 | 27 | 3 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 175 | 27 | 3 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 175 | 27 | 3 | dc7721794162dee96944f4b4b87b5681bb02ea8f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 175 | 27 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.58e-04 | 175 | 27 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 175 | 27 | 3 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 175 | 27 | 3 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 177 | 27 | 3 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 1.63e-04 | 177 | 27 | 3 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.66e-04 | 178 | 27 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 179 | 27 | 3 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.69e-04 | 179 | 27 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 179 | 27 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 179 | 27 | 3 | 2832a9ea1c84b809f4bb5fb39d7ad50af4b33fa9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 179 | 27 | 3 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-04 | 179 | 27 | 3 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 180 | 27 | 3 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 180 | 27 | 3 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-04 | 180 | 27 | 3 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 181 | 27 | 3 | 14faef1dde781d501834379f2a6413e8d6a80b72 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 182 | 27 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | a305667cfdae50e64e1890f10f71b407ae617b80 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | 544939a0bfef082d361d88ef70d6f0923b8d9af9 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 184 | 27 | 3 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 185 | 27 | 3 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 185 | 27 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 185 | 27 | 3 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.89e-04 | 186 | 27 | 3 | 6259f0f2d5bc863782d09a901d6be2f387d1f074 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 187 | 27 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 187 | 27 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 187 | 27 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | droplet-Fat-Mat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | d4113d0aaeefe6e07026cd02cd53ebc13a41a7ac | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 27 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 188 | 27 | 3 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | droplet-Fat-Mat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | c9ed37e71eda66659bf4dd4dbbe4e852eefb8339 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | 1821ae4a6e37ee4c6308071883f3f447a7c53c53 | |
| Drug | AC 110 | 6.66e-09 | 4 | 28 | 3 | CID000022860 | |
| Drug | CAS 298-57-7 | 2.74e-08 | 73 | 28 | 5 | CID000002761 | |
| Drug | 3,4-dihydroquinazoline | 3.32e-08 | 6 | 28 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 3.32e-08 | 6 | 28 | 3 | CID000133976 | |
| Drug | nisoldipine | 3.83e-08 | 78 | 28 | 5 | CID000004499 | |
| Drug | APMPA | 5.81e-08 | 7 | 28 | 3 | CID000512300 | |
| Drug | CNS 1145 | 7.30e-08 | 33 | 28 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.30e-08 | 33 | 28 | 4 | CID000162753 | |
| Drug | CP-80 | 1.05e-07 | 36 | 28 | 4 | CID000452640 | |
| Drug | glutamate | EPHB2 CACNA1A CACNA1B CACNA1E CACNA1S EEF2K HK2 GGCX SLC4A1 PENK | 1.13e-07 | 962 | 28 | 10 | CID000000611 |
| Drug | loperamide | 1.71e-07 | 105 | 28 | 5 | CID000003954 | |
| Drug | AC1L1I54 | 1.80e-07 | 41 | 28 | 4 | CID000004426 | |
| Drug | 4-aminopiperidine | 2.73e-07 | 11 | 28 | 3 | CID000424361 | |
| Drug | leys | 2.73e-07 | 11 | 28 | 3 | CID000484683 | |
| Drug | AC1L2VU3 | 3.64e-07 | 12 | 28 | 3 | CID000129572 | |
| Drug | AC1L1JG6 | 6.01e-07 | 14 | 28 | 3 | CID000005026 | |
| Drug | Cinildipine | 6.43e-07 | 56 | 28 | 4 | CID000002752 | |
| Drug | butamben | 7.50e-07 | 15 | 28 | 3 | CID000002482 | |
| Drug | etorphine | 7.95e-07 | 59 | 28 | 4 | CID000026721 | |
| Drug | N-methyl-DL-aspartic acid | 8.40e-07 | 655 | 28 | 8 | CID000004376 | |
| Drug | nilvadipine | 8.51e-07 | 60 | 28 | 4 | CID000004494 | |
| Drug | nimodipine | 8.54e-07 | 145 | 28 | 5 | CID000004497 | |
| Drug | IAA-94 | 9.10e-07 | 61 | 28 | 4 | CID000003667 | |
| Drug | pentasulfane | 9.23e-07 | 16 | 28 | 3 | CID000448216 | |
| Drug | Verapamil | 9.23e-07 | 16 | 28 | 3 | DB00661 | |
| Drug | Bay K 8644 | 1.01e-06 | 150 | 28 | 5 | CID000002303 | |
| Drug | lercanidipine | 1.04e-06 | 63 | 28 | 4 | CID000065866 | |
| Drug | AC1L1TJF | 1.25e-06 | 66 | 28 | 4 | CID000003377 | |
| Drug | gallopamil | 1.33e-06 | 67 | 28 | 4 | CID000001234 | |
| Drug | calmidazolium chloride | 1.39e-06 | 160 | 28 | 5 | CID000002531 | |
| Drug | DCG-IV | 1.41e-06 | 68 | 28 | 4 | CID000115114 | |
| Drug | norcepharadione B | 1.46e-06 | 2 | 28 | 2 | CID000189168 | |
| Drug | aristolactam AII | 1.46e-06 | 2 | 28 | 2 | CID000148657 | |
| Drug | alkosin | 1.46e-06 | 2 | 28 | 2 | CID005488638 | |
| Drug | piperolactam A | 1.46e-06 | 2 | 28 | 2 | CID003081016 | |
| Drug | AC1L2AC7 | 1.50e-06 | 69 | 28 | 4 | CID000068733 | |
| Drug | N6-Me-dAdo | 1.59e-06 | 19 | 28 | 3 | CID000168948 | |
| Drug | pranidipine | 1.59e-06 | 19 | 28 | 3 | CID006436048 | |
| Drug | gabapentin | 1.82e-06 | 169 | 28 | 5 | CID000003446 | |
| Drug | ethosuximide | 1.98e-06 | 74 | 28 | 4 | CID000003291 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.58e-06 | 79 | 28 | 4 | CID005287890 | |
| Drug | NSC7524 | 2.62e-06 | 182 | 28 | 5 | CID000005657 | |
| Drug | LY320135 | 2.90e-06 | 23 | 28 | 3 | CID005311257 | |
| Drug | alpha-conotoxin SI | 2.90e-06 | 23 | 28 | 3 | CID000163979 | |
| Drug | NSC759576 | 3.31e-06 | 191 | 28 | 5 | CID000003075 | |
| Drug | K-Cl | 4.30e-06 | 567 | 28 | 7 | CID000004873 | |
| Drug | mAHP | 4.78e-06 | 27 | 28 | 3 | CID000220531 | |
| Drug | eniluracil | 4.78e-06 | 27 | 28 | 3 | CID000043157 | |
| Drug | Virginiamycin S1 | 5.35e-06 | 28 | 28 | 3 | CID000122731 | |
| Drug | manidipine | 5.39e-06 | 95 | 28 | 4 | CID000004008 | |
| Drug | isotetrandrine | 5.86e-06 | 97 | 28 | 4 | CID000005422 | |
| Drug | nitrendipine | 6.10e-06 | 98 | 28 | 4 | CID000004507 | |
| Drug | isradipine | 6.61e-06 | 100 | 28 | 4 | CID000003784 | |
| Drug | AC1L1D9R | 7.44e-06 | 103 | 28 | 4 | CID000002254 | |
| Drug | 3-aminopropylphosphinic acid | 8.07e-06 | 32 | 28 | 3 | CID006335948 | |
| Drug | KN-62 | 8.19e-06 | 230 | 28 | 5 | CID000003838 | |
| Drug | pyraclofos | 8.34e-06 | 106 | 28 | 4 | CID000093460 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 8.72e-06 | 233 | 28 | 5 | CID000005114 | |
| Drug | Decyl-plastoquinone | 8.74e-06 | 4 | 28 | 2 | CID006426906 | |
| Drug | fluspirilene | 9.72e-06 | 34 | 28 | 3 | CID000003396 | |
| Drug | 3-7a | 1.16e-05 | 36 | 28 | 3 | CID011987860 | |
| Drug | lamotrigine | 1.19e-05 | 116 | 28 | 4 | CID000003878 | |
| Drug | AC1NBU2S | 1.23e-05 | 117 | 28 | 4 | CID004473765 | |
| Drug | NiCl2 | 1.32e-05 | 119 | 28 | 4 | CID000024385 | |
| Drug | 8-cyclopentyltheophylline | 1.37e-05 | 38 | 28 | 3 | CID000001917 | |
| Drug | 3,4-diaminopyridine | 1.37e-05 | 38 | 28 | 3 | CID000005918 | |
| Drug | almagel | 1.46e-05 | 5 | 28 | 2 | CID003080942 | |
| Drug | S 8510 | 1.46e-05 | 5 | 28 | 2 | CID005488383 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 1.48e-05 | 39 | 28 | 3 | CID003331970 | |
| Drug | E 14 | 1.48e-05 | 39 | 28 | 3 | CID000122591 | |
| Drug | bepridil | 1.65e-05 | 126 | 28 | 4 | CID000002351 | |
| Drug | amlodipine | 1.65e-05 | 126 | 28 | 4 | CID000002162 | |
| Drug | pimozide | 1.70e-05 | 127 | 28 | 4 | CID000016362 | |
| Drug | Fk 888 | 1.85e-05 | 42 | 28 | 3 | CID000107967 | |
| Drug | 5'-CG-3 | 2.13e-05 | 44 | 28 | 3 | CID000482125 | |
| Drug | lanthanum | 2.23e-05 | 136 | 28 | 4 | CID000023926 | |
| Drug | amphetamine | 2.26e-05 | 284 | 28 | 5 | CID000003007 | |
| Drug | h PM | 2.28e-05 | 45 | 28 | 3 | CID005494424 | |
| Drug | nor-BNI | 2.44e-05 | 46 | 28 | 3 | CID000004533 | |
| Drug | isovalerate | 2.72e-05 | 143 | 28 | 4 | CID000010430 | |
| Drug | L024104 | 2.78e-05 | 48 | 28 | 3 | CID003025353 | |
| Drug | Dantrolene-13C3 | 2.87e-05 | 145 | 28 | 4 | CID000002951 | |
| Drug | nicardipine | 2.87e-05 | 145 | 28 | 4 | CID000004473 | |
| Drug | AC1L1DXE | 2.90e-05 | 299 | 28 | 5 | CID000002548 | |
| Drug | Amlodipine | 3.05e-05 | 7 | 28 | 2 | DB00381 | |
| Drug | barium | 3.11e-05 | 148 | 28 | 4 | CID000104810 | |
| Drug | KW-3049 | 3.14e-05 | 50 | 28 | 3 | CID000002324 | |
| Drug | procaine | 3.54e-05 | 153 | 28 | 4 | CID000004914 | |
| Drug | lindane | 3.63e-05 | 154 | 28 | 4 | CID000000727 | |
| Drug | nefiracetam | 4.42e-05 | 56 | 28 | 3 | CID000071157 | |
| Drug | felodipine | 5.22e-05 | 169 | 28 | 4 | CID000003333 | |
| Drug | liriodenine | 5.22e-05 | 9 | 28 | 2 | CID000010144 | |
| Drug | lavendustin A | 5.46e-05 | 171 | 28 | 4 | CID000003894 | |
| Drug | riluzole | 5.85e-05 | 174 | 28 | 4 | CID000005070 | |
| Drug | Russian VX | 6.00e-05 | 62 | 28 | 3 | CID000178033 | |
| Drug | EGTA-AM | 6.00e-05 | 62 | 28 | 3 | CID000121907 | |
| Drug | papaverine | 6.11e-05 | 176 | 28 | 4 | CID000004680 | |
| Drug | smilageninoside | 6.52e-05 | 10 | 28 | 2 | CID000197391 | |
| Drug | mibefradil | 6.60e-05 | 64 | 28 | 3 | CID000060662 | |
| Drug | amsonine | 6.81e-05 | 181 | 28 | 4 | CID000002866 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.37e-10 | 3 | 25 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.15e-09 | 4 | 25 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.88e-08 | 7 | 25 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 2.07e-06 | 3 | 25 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.04e-05 | 163 | 25 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 3.16e-04 | 31 | 25 | 2 | DOID:3328 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGLFMSEMFIKMYGL | 526 | O00555 | |
| LGLFLLEMSLKMYGM | 516 | Q15878 | |
| VLMAGTFFFAMMLRK | 576 | P02730 | |
| GLMYAGFILIMATLM | 271 | Q8IUA7 | |
| FLGLFLTEMSLKMYG | 521 | Q00975 | |
| YMNLLGMIFSMCGLM | 36 | Q9Y284 | |
| ALGYITMAKMGLSEM | 661 | Q9ULI1 | |
| RYGGFMKKMDELYPM | 106 | P01210 | |
| HMLLKVMGFGLYLMD | 261 | Q7L576 | |
| MFYFLAMLSMIDLGL | 61 | Q8NGH9 | |
| LKIYLMMLFIGMYFT | 196 | Q5VWC8 | |
| QMGMRSLYFFLCGIM | 376 | Q8IYD8 | |
| QLFEKMISGMYMGEL | 291 | P52789 | |
| MLRGIAAGMKYLADM | 726 | P29323 | |
| MYYFLSMLAMSDLGL | 61 | Q8NGJ7 | |
| MYYFLSMLAMSDLGL | 61 | Q8NGJ6 | |
| HMLLKVMGFGLYLMD | 261 | Q96F07 | |
| ILNGLMMGLFFMYGA | 251 | Q6NUT2 | |
| KMGGMKYIFSLLFFL | 6 | Q9BU40 | |
| LLSLFTTEMLMKMYG | 471 | Q13698 | |
| MKMYGLGLRQYFMSI | 481 | Q13698 | |
| MLRGIASGMKYLSDM | 726 | P29320 | |
| MMLAREAEMLFTGGY | 666 | O00418 | |
| KMMIMGCIFYVGDAI | 866 | Q08211 | |
| SFMYMIAGLCMLKLY | 581 | Q8NBJ9 | |
| MMYALFLLSVGLVMG | 1 | P03923 | |
| YLVYTIMFLGALGMM | 116 | P38435 | |
| IMFLGALGMMLGLCY | 121 | P38435 | |
| SFMYMIAGLCMLKLY | 576 | Q9NXL6 | |
| GGVFYSIMKKTMGMA | 921 | Q96JH7 | |
| LDFMRSFMLKDMLYL | 446 | Q53EQ6 |